Athos, an autoimmune and cancer biotech, is raising $35M for clinical trials
16 Feb 2024 //
ENDPTS
Athos Receives Regulatory Approval to Commence Phase I Trial of ATH-063
29 Mar 2023 //
PR NEWSWIRE
Athos, Caltech Announces Proteomics Research Collaboration for IBD
25 Aug 2022 //
PRNEWSWIRE